跳至主要内容
临床试验/NCT02651324
NCT02651324已完成4 期

A Prospective, Randomized, Double-Blind, Controlled Trial Evaluating the Efficacy of Ketamine for Improvement in Postoperative Pain Control After Spinal Fusion for Idiopathic Scoliosis

Albany Medical College1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2013年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
50
试验地点
1
主要终点
Patient Satisfaction

研究概览

简要总结

This study hypothesizes that the addition of a low-dose ketamine infusion to usual post-operative pain management will improve pain control as evidenced by an improvement in post-operative pain scores for patients undergoing spinal fusion for idiopathic scoliosis.

详细描述

After consenting, patients will be randomized by the pharmacy. In the operating room patients will receive ketamine/placebo 0.5mg/kg bolus prior to the surgical incision, followed by ketamine/placebo 0.2mg/kg continuous infusion up to 48hours. All the patients will also receive 15mg/k IV acetaminophen at the end of the surgery, followed by every 6hr for 48hrs. Rest of the pain regimen will be the usual post-operative pain management for spinal fusion for idiopathic scoliosis, which includes morphine PCA, IV ketorolac from POD 1, and flexaril from POD 1.

All the patients and parents will fill out a survey at 0hr, 24hr and 48hr grading their level of satisfaction with the post-operative pain.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

性别
All
接受健康志愿者

入选标准

  • ASA I, II, III
  • Presenting for spinal fusion for idiopathic scoliosis
  • English-speaking and able to give assent

排除标准

  • Any contraindication to ketamine
  • Previous spinal surgery
  • Opioid dependence
  • Chronic pain condition
  • Significant developmental delay
  • Pregnancy

研究组 & 干预措施

Treatment Group

Experimental

A ketamine bolus of 0.5mg/kg will be given and then the ketamine infusion of 0.2 mg/kg/hr will be initiated prior to incision. Intra-operative opioids will be at the discretion of the attending anesthesiologist. Postoperative management will include continuation of the study drug as well as a standardized morphine patient-controlled analgesia (PCA) and acetaminophen 15 mg/kg IV every 6 hours. On postoperative day 1, patients are started on ketorolac 0.5 mg/kg up to 15 mg IV q8h. On postoperative day 2 they are transitioned to ibuprofen 10 mg/kg up to 600 mg. The ketamine infusion will continue for 48 hours post operatively at which point the PCA is discontinued and patients are transitioned to oral pain medications (Roxicet or Lortab and Flexeril) as per the current protocol.

干预措施: Ketamine (Drug)

Placebo

Placebo Comparator

A placebo (saline) will be given in place of ketamine

干预措施: Placebo (Other)

结局指标

主要结局

Patient Satisfaction

时间窗: Through study completion, 48 hours

All the patients and parent will fill out a survey grading their level of satisfaction with their post-operative pain management. Patient Satisfaction Score from a scale of 1 - 4 was used - 1. Unsatisfied 2. Moderately satisfied 3 - Generally satisfied 4 - Very satisfied No other subscales were included.

次要结局

  • Pain Score(Through study completion 48 hours)
  • Opioid Use(Through study completion, 48 hours)
  • Length of Stay(Through study completion, 48 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Farzana Afroze

Anesthesiologist

Albany Medical College

研究点 (1)

Loading locations...

相似试验